MedTrace Logo

Effects of Recursive Self-feedback on Speech Production in Aphasia

NCT06323629 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2024-03-21

No results posted yet for this study

Summary

The goal of this clinical trial is to test the effects of recursive self-feedback procedures on spontaneous speech production in stroke survivors with impaired speech production (aphasia). The main question it aims to answer is:

• To what extent can stroke survivors with aphasia use their self-feedback alone to improve their spontaneous speech production?

Participants will be engaged in the following activities:

* They will perform language and cognitive tasks.
* Afterwards, they will receive treatments using tablets and headphones at no cost to them.
* The experimental treatments (recursive self-feedback procedures) entails responding to prompts, listening to playbacks of their speech response and attempt to minimize/correct the errors in the next attempt. This process will be repeated multiple times per prompt.
* The experimental treatments are two: an adaptive version that adapts the complexity of the treatment prompt and a non-adaptive version that does not adapt task complexity.
* Researchers will compare the experimental treatments to see if both have similar effects on improving spontaneous speech production.

Conditions

Interventions

BEHAVIORAL

Adaptive recursive self-feedback procedure

The intervention uses self-feedback alone to improve speech production. It adapts the complexity of the treatment tasks.

BEHAVIORAL

Non-adaptive recursive self-feedback procedure

The intervention uses self-feedback alone to improve speech production. However, it does not adapt the complexity of the treatment tasks.

Sponsors & Collaborators

  • Center for Smart Use of Technologies to Assess Real-world Outcomes

    collaborator UNKNOWN

  • University of South Florida

    lead OTHER

Principal Investigators

  • Gerald C. Imaezue, PhD · University of South Florida

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-30
Primary Completion
2025-03-31
Completion
2025-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06323629 on ClinicalTrials.gov